<DOC>
	<DOCNO>NCT01404338</DOCNO>
	<brief_summary>Tachyphylaxis occur medication apply multiple time decrease response take place . Many dermatologist believe tachyphylaxis topical steroid commonly occur . Other believe tachyphylaxis explain patient non-compliance topical medication . This study look prove disprove phenomenon tachyphylaxis use topical steroid psoriasis patient population . The investigator look enroll 10 patient symmetric , bilateral , small psoriasis plaque . The investigator either apply strong topical steroid vehicle ointment plaque , occlude band aid one week period . Weekly , investigator inspect plaque tachyphylaxis . This regimen repeat phase 2 , see change time tachyphylaxis . This regimen repeat phase 3 , however , plaque treat steroid phase , time tachyphylaxis measure .</brief_summary>
	<brief_title>Assessment Tachyphylaxis Topical Corticosteroids Treatment Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Halobetasol</mesh_term>
	<criteria>Subjects must least 18 year age good general health confirm medical history . Females childbearing potential must negative urine pregnancy test Baseline/Week 0 must agree use adequate birth control method entire study ( barrier method i.e . condom , diaphragm ; hormonal contraceptive i.e . birth control pill , implant , injection ; intrauterine device , abstinence ) . Subjects must diagnose stable plaque psoriasis affect 1 % 10 % body surface area ( exclude face , scalp , groin , axillae intertriginous area ) . Subjects receive phototherapy psoriasis . Subjects must least two symmetrical lesion suitable evaluate response test agent ( one right side one leave side body ) . The severity disease target lesion Baseline/Week 0 must rat least 2 ( Mild ) key psoriasis characteristic ( scale , erythema , plaque elevation ) Target Lesion Severity Score . Subjects must able understand requirement study abide restriction return require examination . Female subject pregnant , nurse plan pregnancy study . Subjects know hypersensitivity component test medication . Subjects nonplaque psoriasis ( e.g . guttate , erythrodermic ) relate disease classify plaque psoriasis . Subjects whose psoriasis involve scalp , face , groin , axilla , and/or intertriginous area . Subjects require medication ( topical systemic ) may affect course disease study period determine study investigator . Subjects use biologics systemic treatment ( e.g . immunosuppressant , acitretin ) psoriasis within 12 week enter study . Subjects use systemic corticosteroid within 28 day enter study Subjects use topical corticosteroid topical therapy ( emollient ) treatment area location within 14 day enter study Subjects use phototherapy ( UVB , PUVA ) target treatment site within 4 week enter study . Subjects overt preexisting telangiectasias skin atrophy intend treatment site ( treatment area ) . Subjects use medication disease judgment investigator interfere conduct interpretation study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>